MR1 and cancer: The attractiveness of this discovery comes from the unvaried nature of MR1, due to its mandatory involvement in some microbial metabolism pathways, as well as MR1 expression on many cancer types cells but not healthy cells, which makes it a good candidate for ACT immunotherapy.